Revvity

Revvity, formerly PerkinElmer, is a global leader in life science tools, diagnostics, and applied analytics. After divesting its analytical instruments and industrial businesses, Revvity refocused on life sciences and diagnostics. The company's HTRF (Homogeneous Time-Resolved Fluorescence) technology is a cornerstone of drug discovery assays, enabling highly sensitive detection of protein-protein interactions and enzymatic activity in homogeneous formats ideal for high-throughput screening. Revvity's EnVision and EnSight multimode plate readers are industry standards in pharmaceutical research labs for their flexibility across luminescence, fluorescence, and absorbance readouts. The Opera Phenix and Operetta CLS high-content imaging systems allow researchers to perform cell-based phenotypic screening at scale, combining automated microscopy with Columbus image analysis software. Revvity also provides radiochemicals, labeled compounds, and scintillation counting equipment through its PerkinElmer Radiochemical brands. In neonatal screening, they supply bloodspot analysis instruments and reagents used by national newborn screening programs globally. Their Signals research informatics platform connects experimental data, bioinformatics, and laboratory operations, making Revvity relevant across the translational research pipeline from target identification to clinical biomarker development.